- Supplements Facts
- Client Reviews
Protect Against Mental Decline with Stabilized TruePS™!
Phosphatidylserine (PS) is one of the body’s essential building blocks. It’s naturally found in the cell membrane and particularly abundant in the brain. In general, the human brain is very rich in lipid (fat) content. And PS accounts for about 18% of all phospholipids in the brain – indicating its importance to cognitive function.
PS is crucial to the structure and function of nerve cells and plays a key role in cell-to-cell communication, information transfer, signaling and more.
The daily intake of PS is reduced in modern diets – largely due to a greater focus on lower fat foods. For example, it’s estimated that the average individual consumed approximately 250mg of PS daily from food prior to the 1980s. Today the average person gets only about 130mg of PS daily from food (and a vegetarian diet provides only about 50mg/day).
Research indicates beneficial effects for supplementing our daily diet with 100mg to 300mg per day of PS (each TruePS™ soft gel provides 100mg of stabilized soy-free Sharp PS® Green).
The body of scientific evidence supporting the benefits of PS includes 30 clinical studies addressing the entire human life cycle – from children to adults to seniors. Here’s a summary of the PS findings:
- May help slow age-related mental decline, improving memory, attention and concentration.
- May help support a balanced mood and blunt feelings of stress.
- May help reduce risk of cognitive dysfunction and protect brain cells.
These benefits are possible only if you’re using a “stabilized” PS supplement. Unfortunately, PS is highly unstable and prone to degradation (and taking degraded PS won’t help you). In fact, a recent study showed a standard PS product may degrade by as much as 20% within 4.5 months of encapsulation.
TruePS™ overcomes this concern by using a special stabilization process. Shelf life research has indicated that even after 24 months, the PS showed absolutely no degradation.
The Importance of Choosing a “Stabilized” Phosphatidylserine (PS) Supplement
Phosphatidylserine (PS) is a phospholipid that is a major component of cell membranes, making it a highly valuable nutrient for enhancing cognitive function. Without sufficient levels of PS, brain cells do not transmit nerve impulses properly.
TruePS™ is made with soy-free Sharp PS® Green - a high purity phosphatidylserine (PS) brand, developed and produced in Israel by Enzymotec Ltd. under the highest quality and safety standards.
Sharp PS® can have a positive effect on memory recognition, memory recall, executive functions and mental flexibility.
Even though Sharp PS® Green is a very high quality PS, it like other phosphatidylserine is highly unstable and prone to degradation over time.
As you might expect, when PS degrades, it is of little value to your brain cells.
To overcome the issue of PS stability, Soft Gel Technologies® has developed a method to enhance Sharp PS® Green using an exclusive fluid dispersion (provided as finished dosage soft gels) that has enviable stability.
Shelf-life studies on this stabilized Sharp PS®, performed by an independent laboratory, found that even after 24 months, the material showed absolutely no degradation.
This allows you to use every bottle of TruePS™ with confidence, knowing that the PS is active and able to provide maximum benefits.
Dietary Supplement / 30 Softgels
Serving Size: 1 Softgel
Servings per Container: 30
|Amount Per Serving||% Daily Value|
|Phosphatidylserine ComplexSharp-PS®||500 Mg||N/A*|
* Daily Value not established.
Other Ingredients: Gelatin, glycerin, polyglycitol syrup, purified water.
Sharp-PS® Green is a registered trademark of Frutarom.
Suggested Use: Take three (3) soft gels a day for the first 4 weeks. Thereafter, a maintenance serving of one (1) soft gel a day is typically recommended, or use as directed by your health care practitioner.
TruePS™ is a highly purified and stabilized phosphatidylserine (PS) that supports brain health.†
- Keep out of reach of children
- Do not use if seal is broken or missing
- Store in a cool dry place
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- BPA Free
- Assembled in the USA
Manufactured for and Distributed by: NatureCity®
Boca Raton, FL 33487 www.naturecity.com
To re-order call toll free 1-800-593-2563
Richter Y, Herzog Y, Lifshitz Y, Hayun R, Zchut S. Journal of Clinical Interventions in Aging. 2013;8:557-63.
Richter Y, Herzog Y, Eyal I, Cohen T. J Diet Suppl 2011 Jun; 8(2):158-68.
Richter Y, Herzog Y, Cohen T, Steinhart Y. Journal of Clinical Interventions in Aging. 2010; 5: 313–316.
Vaisman N. Phosphatidylserine may improve cognitive abilities in elderly with memory complaints: an open label trial – In preparation.
Hirayama S, Terasawa K, Rabeler R, Hirayama T, Inoue T, Tatsumi Y, Purpura M, Jäger R Journal of Human Nutrition and Dietetics. 2014 Apr;27 Suppl 2:284-91.
Yong T, Qianyong Z, Mantian M, Gang H, Jing W. Chongqing Medicine. 2011; 30:3022-23 3026.
Parker AG, Gordon J, Thornton A, Byars A, Lubker J, Bartlett M, Byrd M, Oliver J, Simbo S, Rasmussen C, Greenwood M, Kreider RB. Journal of the International Society of Sports Nutrition. 2011 Oct 21;8:16.
Gindin J, Novikov M, Dedar D, Walter- Ginzburg A, Naor S, Levi S. The Geriatric Institute for Education and Research, and Department of Geriatrics, Kaplan Hospital, Rehovot, Isryongael. Unpublished report; 2009.
Schreiber, S.,0. Kampf-Sherf, M. Gorfine, D. Kelly, Y. Oppenheim, B. Lerer.. Israel Journal of Psychiatry and Related Sciences 2000 37: 302-307.
Kato-Kataoka A, Sakai M, Ebina R, Nonaka C, Asano T, Miyamori T. Journal of Clinical Biochemistry and Nutrition. 2010 Nov; 47(3): 246–255.
Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Dementia and Geriatric Cognitive Disorders. 2010;29(5):467-74.
Starks M, Starks S, Kingsley M, Purpura M, Jäger R. 2008 Jul 28;5:11.
Baumeister J, Barthel T, Geiss KR, Weiss M. Nutritional Neuroscience. 2008 Jun;11(3):103-10.
Jäger R, Purpura M, Geiss K, Weiss M, Baumeister J, Amatulli F, Schröder L, Herwegen H. Journal of the International Society of Sports Nutrition. 2007 Dec; 4:23.
Jorissen, B.L., F. Brouns, M.P.J. van Boxtel, R.W.H.M. Ponds. F.R.J. Verhey, J. Joiles, W.J. Riedel. Nutritional Neuroscience 2001.4: 121-134.
Crook, T. H. Vol 11, edited by R.M. Klatz, Health Quest Publications, 1998.Chicago, pp. 20-29.
Heiss, W.-D., J. Kessler, R. Mielke, B. Szelies, K. Herholz. Dementia 1994. 5: 88-98.
Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Aging (Milano). 1993 Apr;5(2):123-33.
Crook T, Petrie W, Wells C, Massari DC. Psychopharmacology Bulletin. 1992;28(1):61-6.
Engel, R.R., W. Satzger,W. Gunther,N. Kathmann,D. Bove, S.Gerke, U.Munch, H. Hippius. European Neuropsychopharmacol 1992.2:149-1 55.
Crook T, Tinklenberg J, Yesavage J, Petrie W, Nunzi M, Massari D. Neurology. May 1991 vol. 41 no. 5 644-649.
Klinkhammer P. Szelies B. Heiss W. Dementia and Geriatric Cognitive Disorders. 1990;1:197–201.
Puca, F.M., M.A. Bavarese, M.G. Minervini. Clinical Trials Journal 1987. 24: 94- 98.
Maggioni, M., G.B. Picotti, G.P. Bondiolotti, A. Panerai, T. Cenacchi, P. Nobile, F. Brambilla. Acta Psychiatrica Scandinavica 1990. 8 1 : 265-270.
Rabboni, M., F.S. Maggioni, A. Giannelli, L. Beinat. Clinical Trials Journal 1990. 27: 230-240.
Hershkowitz, M., M. Fisher, D. Bobrov, M. Rabinowitz. N.G. Bazan, L.A. Horrocks, G. Toffano (eds). Liviana Press, Padova; 1989. pp. 279-288.
Amaducci, L. and the SMID group. Psychopharmacol Bulletin 1988.24: 130-134.
Allegro, L., V. Favaretto, G. Ziliotto. Clinical Trials Journal 1987.24: 104-108.
Granata, Q., J. Di Michele. Clinical Trials Journal 1987. 24: 99-103.
Caffarra, P., V. Santamaria. Clinical Trials Journal 1987.24: 109 - 114.
Sinforiani, E., C. Agostinis, P. Merlo, S. Gualtieri, M. Mauri, A. Mancuso. Clinical Trials Journal.1987. 24: 115-124.
Palmieri, G., R. Palmieri, M.R. Inzoll, A.M. Agrati, A Vargiu. Clinica Trials Journal 1987. 24: 73-83.
Villardita, J.C., S. Grioli, G. Salmeri, F. Nicoletti, G. Pennisi. Clinical Trials Journal 1987. 24: 84-93.
Delwaide, P.J., A.M.Gyselynck-Mamboug, A. Hurlet, M. Ylieff. Acta Neurologrca Scandinavica 1986. 73: 136-140.
*The views and opinions expressed by contributors and or product reviews are their own and not
necessarily those of NatureCity. These reviews should not be taken as recommendations but rather
client opinions of the products that they have used.